Your gift is 100% tax deductible.
Early Detection, Diagnosis, and Staging of Gastrointestinal Stromal Tumors
Learn about the signs and symptoms of gastrointestinal stromal tumors (GIST), the tests that are done to diagnose and stage the disease, and the outlook for people diagnosed with it.
Can GISTs be found early?
GISTs are not common. At this time, there are no recommended screening tests to look for GISTs in people without risk factors or symptoms.
If you have a genetic syndrome that increases your risk of GISTs, talk with your doctor about whether imaging tests or procedures might be recommended to detect tumors early and treat them.
Most GISTs are found because of symptoms a person is having, but some GISTs might be found early by chance. Sometimes a GIST might be found on an imaging test or procedure, like a colonoscopy, done for another reason.
What are the signs and symptoms of GISTs?
Some GISTs cause no symptoms and are found by chance when a test is done for another reason.
More common symptoms of GISTs include:
- Vomiting blood, which can be bright red blood or blood that is partly digested and looks like coffee grounds
- Blood in the stool, which might be bright red blood in or on the stool or digested blood, which makes the stool look darker brown or black
- Belly pain or discomfort, which might be severe
- A lump or swelling in the belly
GISTs can also cause low energy, low appetite, or weight loss. Large tumors can block the GI tract or cause damage to the wall of the GI tract, which can be life-threatening and needs treatment right away.
Any of these symptoms could have other causes, but it’s important to check with your health care team so they can find and treat the cause.
How is a GIST diagnosed?
Depending on the location or size of the tumor, diagnosing a GIST might involve physical exams, imaging and blood tests, an endoscopy, and a biopsy of the tumor.
If your health care team suspects you have a GIST, they will do more detailed tests on the tumor sample and might recommend more imaging tests to know if the tumor has spread and the best treatment plan.
Some of these tests might also be used to track how well treatment is working.
Staging and outlook for GISTs
After a GIST diagnosis, many people want to know what to expect. Your cancer care team can use several factors, such as the stage and location of your cancer, how quickly the cells are dividing (mitotic rate), and whether the tumor has ruptured or spread, to help understand your outlook.
Survival rates are a way to measure how many people survive a certain type of cancer over time. These are often reported as 5-year survival rates. This refers to the percentage of people who live at least 5 years after their cancer diagnosis. Of course, many people live much longer.
Questions to ask if you have a GIST
Understanding your diagnosis
- How sure are you that my tumor is a GIST?
- Where is the cancer located? How big is it?
- How likely is this tumor to grow or spread quickly?
- Has my tumor spread beyond where it started?
- What is my cancer's stage, and what does that mean?
- Are there any specific gene changes in my tumor that will affect what treatments you recommend?
- What else do you know about my cancer based on the tests you’ve done?
- Will I need any other tests before we can decide on treatment?
Talking about treatment
- Do I need to see any other doctors or health professionals?
- Who else will be on my treatment team and what will they do?
- Are there any clinical trials we should consider? How can we find out more about them?
- Should I get a second opinion? How do I do that? Can you recommend a doctor or cancer center?
- If I'm concerned about costs and insurance coverage for my diagnosis and treatment, who can help me?
- Written by
- References
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Jacobson BC, Bhatt A, Greer KB, et al. ACG Clinical Guideline: Diagnosis and Management of Gastrointestinal Subepithelial Lesions. Am J Gastroenterol. 2023;118(1):46-58.
National Cancer Institute. Gastrointestinal Stromal Tumors Treatment. Accessed at https://www.cancer.gov/types/soft-tissue-sarcoma/hp/gist-treatment-pdq on December 4, 2025.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Gastrointestinal Stromal Tumors Version 1.2025 – April 17, 2025. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/gist.pdf on December 4, 2025.
Yan M, Lin J, Shu M, et al. Diagnosis, Treatment, and Prognosis of Patients with Primary Familial Gastrointestinal Stromal Tumor: A Case Report and Literature Review. Oncologist. 2023;28(12):e1134-e1141.
Last Revised: March 10, 2026
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.


